Column Group IV, LP, 10% Owner, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 67,271 shares at $13.03 ($877K) on 2022-06-02, disclosed to the SEC on 2022-06-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.03 | 1,129 | $15K | 1.7% |
| 2 | $13.03 | 33,071 | $431K | 49.2% |
| 3 | $13.03 | 33,071 | $431K | 49.2% |
| Total | $13.03 avg | 67,271 | $877K | 100% |
| Filing → |
| NGM | BUY | 2022-05-17 | $842K | — | Filing → |